Table 4 Plasmodium falciparum, Plasmodium vivax and splenomegaly prevalences (%) in ITN and control clusters during the peak season at the end of the study (January 1999)
| Â | N | N | P. falciparum | P. vivax | Spleen | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | ITN | NN | ITN | NN | Prevalence difference | ITN | NN | Prevalence difference | ITN | NN | Prevalence difference |
Dabhine | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Pair 1 | 659 | 708 | 31 (5) | 107 (15) | - 10.4 | 183 (28) | 280 (40) | - 11.8 | 170 (26) | 432 (61) | - 35.2 |
Pair 2 | 508 | 644 | 39 (8) | 35 (5) | + 2.3 | 120 (24) | 135 (21) | + 2.7 | 155 (31) | 131 (20) | + 10.2 |
Pair 3 | 413 | 268 | 17 (4) | 21 (8) | - 3.7 | 57 (14) | 83 (31) | - 17.2 | 63 (15) | 90 (34) | - 18.3 |
Pair 4 | 203 | 169 | 10 (5) | 6 (4) | + 1.4 | 23 (11) | 25 (15) | - 3.5 | 56 (28) | 74 (44) | - 16.2 |
Pair 5 | 62 | 71 | 3 (5) | 7 (10) | - 5.0 | 23 (37) | 22 (31) | + 7.1 | 23 (38) | 31 (44) | - 5.9 |
Myothugyi | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Pair 6 | 65 | 43 | 14 (22) | 3 (7) | + 14.6 | 7 (11) | 1 (2) | + 8.4 | 11 (17) | 4 (9) | + 7.6 |
Pair 7 | 717 | 763 | 2 (0) | 5 (1) | - 0.4 | 0 (0) | 0 (0) | 0 | 6 (1) | 23 (3) | - 2.2 |
Pair 8 | 462 | 580 | 0 (0) | 6 (1) | - 1.0 | 1 (0) | 4 (1) | - 0.7 | 1 (0) | 9 (2) | - 1.3 |
Pair 9 | 627 | 620 | 5 (1) | 3 (0) | + 0.3 | 9 (1) | 2 (0) | + 1.1 | 11 (2) | 3 (0) | + 1.3 |
Pair 10 | 143 | 103 | 40 (28) | 32 (31) | - 3.1 | 23 (16) | 12 (12) | + 4.4 | 37 (26) | 23 (22) | + 3.5 |
Total | 3859 | 3969 | 161 (4) | 225 (6) | Â | 446 (12) | 564 (14) | Â | 533 (14) | 818 (21) | Â |
Weighted Paired t-test |  |  | Pf : -1.9% (−5.8%, 2.0%), | Pv : -2.8% (−8.5%, 2.9%), | Spleen : -7.3% (−20.1%, 5.5%), | ||||||
p-value = 0.30 | p-value = 0.30 | p-value = 0.23 | |||||||||